CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Phase I/II Study of SRP-4053 in DMD Patients [Phase 1, Phase 2]
Summary
Phase I/II study update for SRP-4053 in Duchenne Muscular Dystrophy completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-19